miR-145 downregulates MMP2 expression in lung adenocarcinoma cell A549
10.13602/j.cnki.jcls.2018.02.06
- VernacularTitle:miR-145抑制肺腺癌细胞A549中MMP2的表达
- Author:
Xuelian XIAO
1
;
Daheng YANG
;
Jia WEI
;
Jian XU
Author Information
1. 南京医科大学第一附属医院检验学部
- Keywords:
miR-145;
MMP2;
β-catenin;
lung adenocarcinoma
- From:
Chinese Journal of Clinical Laboratory Science
2018;36(2):102-105
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the regulatory effects of miR-145 on MMP2 expression in lung adenocarcinoma cell A549 and the mechanism involved in the regulation.Methods Lipofectamine 2000 reagent-mediated miR-145 mimic or mimic negative control (NC) was transiently transfected into lung adenocarcinoma cell A549.The expression levels of miR-145 were determined by RT-PCR.MMP2 and β-catenin expression was detected by western blot.Lithium chloride (LiC1),the activator of Wnt/β-catenin pathway,and miR-145 mimic co-processed to act on A549 cells,then the expressions of MMP2 and β-catenin were detected by Western blot.Results The results of RT-PCR showed that the difference of miR-145 in miR-145 mimic group,NC group and blank group was statistically significant(F =296.30,P ＜0.05).western blot showed that the expression levels of MMP2 and nucleus β-catenin were significantly downregulated in miR-145 overexpression group compared with the control (q =8.98,26.59,all P ＜ 0.05).Additionally,the effects of co-processing factors on the cells showed that the activation of wnt/β-catenin pathway reversed the inhibition of miR-145 on MMP2 expression(q =49.47,P ＜ 0.05).Conclusion miR-145 may downregulate MMP2 expression through inhibition of Wnt/β-catenin pathway activity in lung adenocarcinoma cell A549.
